Volume : 10, Issue : 02, February – 2023
Title:
08.DESIGN AND IN-VITRO EVALUATION OF FAST DISINTEGRATING TABLETS OF AN ANTIHYPERTENSIVE DRUG
Authors :
Humera Kouser, Zeenath Ruhy
Abstract :
Aim:The aim of the work was an attempt to make the formulation of fast disintegrating tablets of Diltiazem HCl by direct compression method with the aid of superdisintegrants addition.
Method: Fast disintegrating tablets of Diltiazem HCl were prepared by direct compression method. Nine formulations were developed by using three different superdisintegrants in varying concentrations in such a way that total weight of the tablet remains same. The drug-polymer incompatibility was ruled out by FTIR studies. All the formulated tablets were subjected for pre and post-compression evaluation parameters. A comparison of in vitro drug release of optimized formulation (DF9) was compared with marketed product (Dilzem).
Result: From the FTIR studies, the drug-polymers compatibilities were confirmed. All the formulated tablets were showing satisfactory results which comply with the official limits.
Conclusion: Among the nine formulations, the formulation containing 4.5% crospovidone (DF9) showed highest drug release of 95.72% as compared to other formulations. A comparison of in vitro drug release was made with marketed product of Diltiazem HCl (Dilzem) which shows 92.53% drug release in 1 hour. From this study we can make the conclusion that the formulated tablets of Diltiazem HCl containing crospovidone are better and effective than conventional tablets to meet patient compliance along with fast relief from hypertention and angina.
Keywords: Formulation; FTIR studies; In vitro drug release; Diltiazem HCl; Fast disintegrating tablets; Superdisintegrant etc.
Cite This Article:
Please cite this article in press Humera Kouser et al, Design And In-Vitro Evaluation Of Fast Disintegrating Tablets Of An Antihypertensive Drug., Indo Am. J. P. Sci, 2023; 10 (02).
Number of Downloads : 10
References:
2. Kaur H. Processing technologies for pharmaceutical tablet a review. Int Res J Pharm 2012; 3(7):20-4. http://dx.doi.org/10.3109/03639049809085650
3. Abha, kaur L. Fast dissolving tablet as a novel vital concept a review. Int J Pharm Res Bio Sci 2015; 4(1):308-319. http://dx.doi.org/10.1016/0378-5173(79)90069-3
4. Yadav G, Kapoor A, Bhargava S. Fast dissolving tablets recent: a review. Int J Pharm Sci 2012; 3(3):728-736. http://dx.doi.org/10.1016/S0378-5173(99)00219-7
5. The Indian pharmacopoeia. Published by the controller of publication, Govt. of India, Ministry of Health and family welfare, New delhi 2007; 124,477-480.
6. Hermann P, Rodger SD, Remones G, Thenot JP, London DR, Morselli PL: Pharmacokinetics of diltiazem after intravenous and oral administration. Eur J Clin Pharmacol. 1983;24(3):349-52. [Article]
7. Rodriguez Padial L, Baron-Esquivias G, Hernandez Madrid A, Marzal Martin D, Pallares-Carratala V, de la Sierra A: Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases. Cardiol Ther. 2016 Jun;5(1):75-82. doi: 10.1007/s40119-016-0059-1. Epub 2016 Mar 25. [Article]
8. Nayler WG, Dillon JS: Calcium antagonists and their mode of action: an historical overview. Br J Clin Pharmacol. 1986;21 Suppl 2:97S-107S. doi: 10.1111/j.1365-2125.1986.tb02859.x. [Article]
9. Sutton MS, Morad M: Mechanisms of action of diltiazem in isolated human atrial and ventricular myocardium. J Mol Cell Cardiol. 1987 May;19(5):497-508. [Article]